MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517039252 A) filed by Bioversys Ag, Basel, Switzerland, on April 23, for 'rifabutin analogs for the treatment of disease.'
Inventor(s) include Antraygues, Kevin; Bourotte, Marilyne; Dale, Glenn E.; Defert, Olivier; Gitzinger, Marc; Lociuro, Sergio; Maingot, Mathieu; Trebosc, Vincent; and Willand, Nicolas.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds and pharmaceutical compositions comprising the same for the treatment, amelioration and/or prevention of disease. In some embodiments, the disease is a bacterial infection. In some embodiments, the bacterial infection is caused by one or more bacterium belonging to a genus of non-tuberculous Mycobacteria, preferably M. abscessus."
The patent application was internationally filed on Sept. 29, 2023, under International application No.PCT/EP2023/077054.
Disclaimer: Curated by HT Syndication.
